235 related articles for article (PubMed ID: 22154835)
1. Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 6-methyl-4-[1-(2-substituted-phenylamino-acetyl)-1H-indol-3-yl]-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid ethyl esters.
Sharma SK; Kumar P; Narasimhan B; Ramasamy K; Mani V; Mishra RK; Majeed AB
Eur J Med Chem; 2012 Feb; 48():16-25. PubMed ID: 22154835
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles.
El-Sawy ER; Mandour AH; Mahmoud K; Islam IE; Abo-Salem HM
Acta Pharm; 2012 Jun; 62(2):157-79. PubMed ID: 22750815
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure-activity relationship of novel substituted 4H-chromen-1,2,3,4-tetrahydropyrimidine-5-carboxylates as potential anti-mycobacterial and anticancer agents.
Raju BC; Rao RN; Suman P; Yogeeswari P; Sriram D; Shaik TB; Kalivendi SV
Bioorg Med Chem Lett; 2011 May; 21(10):2855-9. PubMed ID: 21507635
[TBL] [Abstract][Full Text] [Related]
4. Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones.
Beckers T; Sellmer A; Eichhorn E; Pongratz H; Schächtele C; Totzke F; Kelter G; Krumbach R; Fiebig HH; Böhmer FD; Mahboobi S
Bioorg Med Chem; 2012 Jan; 20(1):125-36. PubMed ID: 22169601
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4]thiadiazol-2-yl)methyl-5-oxo-[1,2,4]triazole and 1-(4-phenyl-5-thioxo-[1,2,4]triazol-3-yl)methyl-5-oxo- [1,2,4]triazole derivatives.
Demirbas N; Karaoglu SA; Demirbas A; Sancak K
Eur J Med Chem; 2004 Sep; 39(9):793-804. PubMed ID: 15337292
[TBL] [Abstract][Full Text] [Related]
6. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antimicrobial, and mosquito larvicidal activity of 1-aryl-4-methyl-3,6-bis-(5-methylisoxazol-3-yl)-2-thioxo-2,3,6,10b-tetrahydro-1H-pyrimido[5,4-c]quinolin-5-ones.
Rajanarendar E; Reddy MN; Murthy KR; Reddy KG; Raju S; Srinivas M; Praveen B; Rao MS
Bioorg Med Chem Lett; 2010 Oct; 20(20):6052-5. PubMed ID: 20813527
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of New 3-Heteroarylindoles as Potential Anticancer Agents.
Abdelhamid AO; Gomha SM; Abdelriheem NA; Kandeel SM
Molecules; 2016 Jul; 21(7):. PubMed ID: 27438822
[TBL] [Abstract][Full Text] [Related]
10. Ionic Liquid-Promoted Synthesis of Novel Chromone-Pyrimidine Coupled Derivatives, Antimicrobial Analysis, Enzyme Assay, Docking Study and Toxicity Study.
Tiwari SV; Seijas JA; Vazquez-Tato MP; Sarkate AP; Karnik KS; Nikalje APG
Molecules; 2018 Feb; 23(2):. PubMed ID: 29462951
[TBL] [Abstract][Full Text] [Related]
11. 2,4-Diamino-9H-pyrimido[4,5-b]indol-5-ols: synthesis, in vitro cytotoxic activity, and QSAR investigations.
Dotzauer B; Grünert R; Bednarski PJ; Lanig H; Landwehr J; Troschütz R
Bioorg Med Chem; 2006 Nov; 14(21):7282-92. PubMed ID: 16843672
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimicrobial activity of new (4,4,4-trihalo-3-oxo-but-1-enyl)-carbamic acid ethyl esters, (4,4,4-trihalo-3-hydroxy-butyl)-carbamic acid ethyl esters, and 2-oxo-6-trihalomethyl-[1,3]oxazinane-3-carboxylic acid ethyl esters.
Zanatta N; Borchhardt DM; Alves SH; Coelho HS; Squizani AM; Marchi TM; Bonacorso HG; Martins MA
Bioorg Med Chem; 2006 May; 14(9):3174-84. PubMed ID: 16412654
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of adamantyl substituted pyrimidines.
Orzeszko B; Laudy AE; Starościak BJ; Orzeszko A; Kazimierczuk Z
Acta Pol Pharm; 2004; 61(6):455-60. PubMed ID: 15794338
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel thiophenecarbohydrazide, thienopyrazole and thienopyrimidine derivatives as antioxidant and antitumor agents.
Abu-Hashem AA; El-Shehry MF; Badria FA
Acta Pharm; 2010 Sep; 60(3):311-23. PubMed ID: 21134865
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of some new 1-benzyl and 1-benzoyl-3-heterocyclic indole derivatives.
El-Sawy ER; Bassyouni FA; Abu-Bakr SH; Rady HM; Abdlla MM
Acta Pharm; 2010 Mar; 60(1):55-71. PubMed ID: 20228041
[TBL] [Abstract][Full Text] [Related]
16. Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
Singh P; Kaur P; Luxami V; Kaur S; Kumar S
Bioorg Med Chem; 2007 Mar; 15(6):2386-95. PubMed ID: 17275313
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Src kinase inhibitory and anticancer activities of 1-substituted 3-(N-alkyl-N-phenylamino)propane-2-ols.
Sharma D; Sharma RK; Bhatia S; Tiwari R; Mandal D; Lehmann J; Parang K; Olsen CE; Parmar VS; Prasad AK
Biochimie; 2010 Sep; 92(9):1164-72. PubMed ID: 20447438
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of some novel fused pyrazolopyrimidines as potential anticancer and antimicrobial agents.
Abd El Razik HA; Wahab AE
Arch Pharm (Weinheim); 2011 Mar; 344(3):184-96. PubMed ID: 21384418
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of some 2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-arylethanones: antibacterial, DNA photocleavage, and anticancer activities.
Kumar V; Kaur K; Karelia DN; Beniwal V; Gupta GK; Sharma AK; Gupta AK
Eur J Med Chem; 2014 Jun; 81():267-76. PubMed ID: 24849271
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
